Tag: LLMs

Browse our exclusive articles!

Meta plans to boost AI development to challenge Google and OpenAI

Meta is now offering its AI software to other businesses, including an open-source version of its LLMs, to challenge Google, Microsoft, and OpenAI in AI-powered solutions.

Refuel AI Raises $5M to Develop Training-Ready Datasets using LLMs

Discover how Refuel AI's groundbreaking technology is automating the creation and labelling of datasets for AI models, all while saving valuable time and resources. Now with $5.2m in seed funding.

Workato and OpenAI Collaborate to Revolutionize Business Automation with AI

Workato has partnered with OpenAI to bring AI models to its enterprise automation platform. Workato's AI@Work approach combines automation, integration and AI capabilities to enable businesses to embrace AI at scale. The partnership will bring AI-powered connectors and co-pilots to the platform, allowing users to design better automations and integrations quickly and easily. Workato plans to leverage existing AI models to enable everyone in an organization to build integrations and automations with security and governance. Visit workato.com/ai for more information.

Hedge Fund Two Sigma Skeptical of ChatGPT Hype

Two Sigma, a NY-based hedge fund, contests the hype surrounding Large Language Models (LLMs). Marty Chavez argues that AI has been impactful for decades and LLMs won't be able to predict the stock market.

AI-Generated Discoveries: ChatGPT Creator Sam Altsam Discusses the Future of Innovation

OpenAI CEO Sam Altman discusses using AI to solve various problems humans face, including climate change & curing diseases. A new research paradigm is needed to improve large language models. Exciting potential for AI to discover new ideas & make scientific progress.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img